Cacoub, Patrice
for the CORIMUNO-19 Collaborative Group
8 papers on CoChatORCID 0000-0002-6727-4992
Most cited papers
- Verified
Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia: A Randomized Clinical Trial
Hermine, O., Mariette, X., Tharaux, P.-L., Resche-Rigon, M., Porcher, R., Ravaud, P., CORIMUNO-19 Collaborative Group, Bureau, S., Dougados, M., Tibi, A., et al. (2021) · JAMA Internal Medicine
COVID-19 Clinical Research StudiesRespiratory Support and Mechanisms
Cited by 734
- Verified
Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry
Strangfeld, A., Schäfer, M., Gianfrancesco, M. A., Lawson-Tovey, S., Liew, J. W., Ljung, L., Mateus, E. F., Richez, C., Santos, M. J., Schmajuk, G., et al. (2021) · Annals of the Rheumatic Diseases
COVID-19 Clinical Research StudiesRheumatoid Arthritis Research and Therapies
Cited by 667
- Verified
Diagnosis of 22 New Cases of Bartonella Endocarditis
Raoult, D., Fournier, P. E., Drancourt, M., Marrie, T. J., Etienne, J., Cosserat, J., Cacoub, P., Poinsignon, Y., Leclercq, P., & Sefton, A. M. (1996) · Annals of Internal Medicine
Bartonella species infections researchInfective Endocarditis Diagnosis and Management
Cited by 379
- Verified
Guidelines on the diagnosis and treatment of iron deficiency across indications: A systematic review
Peyrin-Biroulet, L., Williet, N., & Cacoub, P. (2015) · The American Journal of Clinical Nutrition
Iron Metabolism and DisordersErythropoietin and Anemia Treatment
Cited by 328
- Verified
Hepatitis C Virus (HCV) Evades NKG2D-Dependent NK Cell Responses through NS5A-Mediated Imbalance of Inflammatory Cytokines
Sène, D., Levasseur, F., Abel, M., Lambert, M., Camous, X., Hernandez, C., Pène, V., Rosenberg, A. R., Jouvin-Marche, E., Marche, P. N., et al. (2010) · PLoS Pathogens
Immune Cell Function and InteractionHepatitis C virus research
Cited by 113
- Verified
Influence of polyvascular disease on cardiovascular event rates. Insights from the REACH Registry
Suárez, C., Zeymer, U., Limbourg, T., Baumgartner, I., Cacoub, P., Poldermans, D., Röther, J., Bhatt, D. L., Steg, P. G., & REACH Registry Investigatorsa (2010) · Vascular Medicine
Peripheral Artery Disease ManagementDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 106
- Verified
Efficacy and safety of tumor necrosis factor antagonists in refractory sarcoidosis: A multicenter study of 132 patients
Jamilloux, Y., Cohen-Aubart, F., Chapelon-Abric, C., Maucort-Boulch, D., Marquet, A., Pérard, L., Bouillet, L., Deroux, A., Abad, S., Bielefeld, P., et al. (2017) · Seminars in Arthritis and Rheumatism
Sarcoidosis and Beryllium Toxicity ResearchHistiocytic Disorders and Treatments
Cited by 98
- Verified
Antiphospholipid antibodies and thrombotic events in COVID-19 patients hospitalized in medicine ward
Le Joncour, A., Frere, C., Martin-Toutain, I., Gougis, P., Ghillani-Dalbin, P., Maalouf, G., Vieira, M., Marcelin, A.-G., Salem, J.-E., Allenbach, Y., et al. (2021) · Autoimmunity Reviews
Systemic Lupus Erythematosus ResearchCOVID-19 Clinical Research Studies
Cited by 37
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free